Form 8-K - Current report:
SEC Accession No. 0000950170-24-138242
Filing Date
2024-12-19
Accepted
2024-12-19 08:05:07
Documents
12
Period of Report
2024-12-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K asmb-20241219.htm   iXBRL 8-K 49684
2 EX-10.1 asmb-ex10_1.htm EX-10.1 51023
  Complete submission text file 0000950170-24-138242.txt   230071

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT asmb-20241219.xsd EX-101.SCH 31688
14 EXTRACTED XBRL INSTANCE DOCUMENT asmb-20241219_htm.xml XML 4711
Mailing Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35005 | Film No.: 241561019
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)